These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 38004578)

  • 1. Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease-An Overview.
    Lopes SA; Roque-Borda CA; Duarte JL; Di Filippo LD; Borges Cardoso VM; Pavan FR; Chorilli M; Meneguin AB
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy.
    Jacob EM; Borah A; Pillai SC; Kumar DS
    Nanomaterials (Basel); 2020 Dec; 10(12):. PubMed ID: 33316984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
    Jakubczyk D; Leszczyńska K; Górska S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
    Jonkers D; Penders J; Masclee A; Pierik M
    Drugs; 2012 Apr; 72(6):803-23. PubMed ID: 22512365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The single-cell modification strategies for probiotics delivery in inflammatory bowel disease: A review.
    Han M; Lei W; Liang J; Li H; Hou M; Gao Z
    Carbohydr Polym; 2024 Jan; 324():121472. PubMed ID: 37985038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering.
    Mishra J; Stubbs M; Kuang L; Vara N; Kumar P; Kumar N
    Mediators Inflamm; 2022; 2022():9621668. PubMed ID: 35082553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease.
    Verma P; Srivastava A; Srikanth CV; Bajaj A
    Biomater Sci; 2021 Mar; 9(5):1481-1502. PubMed ID: 33404019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M; Feng Y; Liu W
    Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics in the Treatment of Inflammatory Bowel Disease in Adulthood: A Systematic Review.
    Lorentz A; Müller L
    J Gastrointestin Liver Dis; 2022 Mar; 31(1):74-84. PubMed ID: 35306546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies.
    Basso PJ; Câmara NOS; Sales-Campos H
    Front Pharmacol; 2018; 9():1571. PubMed ID: 30687107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
    Ganji-Arjenaki M; Rafieian-Kopaei M
    J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease.
    Bjarnason I; Sission G; Hayee B
    Inflammopharmacology; 2019 Jun; 27(3):465-473. PubMed ID: 31054010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies.
    Liu P; Gao C; Chen H; Vong CT; Wu X; Tang X; Wang S; Wang Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2798-2818. PubMed ID: 34589398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota.
    Ni Y; Zhang Y; Zheng L; Rong N; Yang Y; Gong P; Yang Y; Siwu X; Zhang C; Zhu L; Fu Z
    Life Sci; 2023 Jul; 324():121699. PubMed ID: 37061125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet therapy for inflammatory bowel diseases: The established and the new.
    Durchschein F; Petritsch W; Hammer HF
    World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.